New CenterWatch Report Examines Japan’s Surging Clinical Trials Market

Wednesday, April 1, 2009 03:00 PM

In 2007, drug development in Japan, the world’s second largest pharmaceutical market, exploded six-fold over 2006 and should continue to grow, according to a new CenterWatch report released today.

Japan: Opening the Door to Global Clinical Trials, the fourth in a series of CenterWatch reports on global clinical research markets, takes a look at the reasons for Japan’s dramatic growth, the differences in the country’s approach to clinical research, and government initiatives to attract Big Pharma to conduct simultaneous global clinical trials in Japan.

“New government initiatives have helped to streamline drug review and approval processes, and sponsor companies have responded by including Japan in their global drug development programs more,” said Sara Gambrill, senior editor at CenterWatch and author of the report. “Japan is participating in global drug development at historic levels; however, there is still work to be done there to sustain that growth.”

This is an essential resource for any business seeking to better understand Japan’s clinical trials landscape and what to expect when conducting clinical research there.
 
To purchase Japan: Opening the Door to Global Clinical Trials, visit the CenterWatch bookstore.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs